Collection 圖書 [5/7] 會議論文/會議摘要 [25/32] 期刊論文 [158/158] Siblings MARK LAWRENCE WAHLQVIST(2008-2012) [138/140] 吳易謙 [54/55] 吳秀英 [10/10] 廖本揚 [39/39] 廖玉潔 [63/65] 張新儀 [245/268] 李孟智 [51/54] 李蘭 [28/28] 林培生 [25/25] 林煜軒 [47/47] 林肇堂 [35/35] 梁賡義 [15/15] 江博煌 [72/78] 溫啟邦(2001-2010) [177/188] 潘文涵 [110/115] 熊昭 [369/379] 莊淑鈞 [43/44] 莊紹源 [162/168] 蔡慧如 [162/165] 蔡憶文(1999-2010) [34/34] 藍祚運(2003-2011) [22/23] 許志成 [385/393] 邱亞文(2005-2013) [63/99] 邱弘毅 [49/49] 邱燕楓 [82/82] 郭耿南(2003-2010) [89/105] 鄒小蕙 [101/105] 鍾仁華 [85/86] 陳主智 [61/61] 陳慶餘(2006-2010) [70/70] 陳美惠 [32/32] 陳豐奇 [53/55] 陳麗光 [106/106] 黃國晉 [15/15] 丘政民(2000-2004) [8/8] 其他 [238/244] 劉仁沛(1998-2002) [64/65] 姚姿君(1999-2002) [3/3] 戴東原(2003-2005) [21/22] 李明亮(2003-2007) [6/6] 林仲彥(1999-2005) [31/33] 林錦瑜(2002-2003) [5/5] 涂醒哲(2003-2004) [4/4] 石曜堂(1999-2006) [20/24] 蔡碧紋(2004-2006) [3/4] 陳淑媛(2001-2004) [3/3] Community Statistics 近3年內發表的文件:19(9.64%) 含全文筆數:188(95.43%) 文件下載次數統計 下載大於0次:188(100.00%) 下載大於100次:177(94.15%) 檔案下載總次數:94826(1.77%) 最後更新時間: 2024-11-28 13:06 Top Upload Loading... Top Download Loading... Recent Submissions Registry of genetic alterations of ... A statistical method for protocol m... Immune killer cells treatment for p... Survival of advanced/recurrent gast... The clinical characteristics and ma... A phase 1 study of biweekly nab-pac... The registry of genetic alterations... Nivolumab plus ipilimumab (N plus I... Polygenic risk score, environmental... Genome-wide association study of lu...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 51-75 of 197. (8 Page(s) Totally) << < 1 2 3 4 5 6 7 8 > >> View [10|25|50] records per page

Date	Title	Relation
2017-07	Exposure sources and their relative contributions to urinary phthalate metabolites among children in Taiwan	International Journal of Hygiene and Environmental Health. 2017 Jul;220(5):869-879.
2017-06-30	Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints	PLoS ONE. 2017 Jun 30;12(6):Article number e0180405.
2017-05	Efficient group-sequential designs for monitoring two time-to-event outcomes in clinical trials	Trials. 2017 May;18(Suppl. 1):Meeting Abstract P36.
2017-03	Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line TKIs	American Journal of Respiratory and Critical Care Medicine. 2017 Mar;195(5):663-673.
2017-03	An approach for sample size determination of average bioequivalence based on interval estimation	Statistics in Medicine. 2017 Mar;36(7):1068-1082.
2017-02	Integrated care for geriatric frailty and sarcopenia: A randomized control trial	Journal of Cachexia, Sarcopenia and Muscle. 2017 Feb;8(1):78-88.
2017-01	Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations	Human Molecular Genetics. 2017 Jan;26(2):454-465.
2016-11-11	Assessing benefit and consistency of treatment effect under a discrete random effects model in multiregional clinical trials	Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics. 2016 Nov 11:127-136.
2016-10	The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study	Annals of Oncology. 2016 Oct;27(Suppl.6 ):Meeting Abstract 973P.
2016-06	Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials	Statistics in Medicine. 2016 Jun;35(14):2301-2314.
2016-04-21	The discrete random-effects model-assessing benefit and consistency of treatment effect	Multiregional Clinical Trials for Simultaneous Global New Drug Development. 2016 Apr 21:245-258.
2016-01-04	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women	Human Molecular Genetics. 2016 Jan 4;25(3):620-629.
2016-01	A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial	Medicine. 2016 Jan;95(3):Article number e2565.
2015-12	Analysis of heritability and shared heritability based on genome-wide association studies for 13 cancer types	Journal of the National Cancer Institute. 2015 Dec;107(12):Article number djv279.
2015-12	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial	Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
2015-10	Quality of life changes in patients undergoing treatment for hepatocellular carcinoma	Quality of Life Research. 2015 Oct;24(10):2499-2506.
2015-10	Estrogen receptor gene polymorphisms and lung adenocarcinoma risk in never-smoking women	Journal of Thoracic Oncology. 2015 Oct;10(10):1413-1420.
2015-09-01	Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients	International Journal of Cardiology. 2015 Sep 1;194:36-38.
2015-07	Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia	International Journal of Cancer. 2015 Jul;137(2):311-319.
2015-05	Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4101.
2015-05	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
2015-03	Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)	Human Genetics. 2015 Mar;134(3):333-341.
2014-12	Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33	Human Molecular Genetics. 2014 Dec;23(24):6616-6633.
2014-10-13	Sample size determination for individual bioequivalence inference	PLoS ONE. 2014 Oct 13;9(10):Article number e109746.
2014-10	Use of a bayesian approach to design and evaluation of NCE2	Pharmacoepidemiology and Drug Safety. 2014 Oct;23(S1):432.

Showing items 51-75 of 197. (8 Page(s) Totally) << < 1 2 3 4 5 6 7 8 > >> View [10|25|50] records per page